Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12118414 BCL-2 proteins degraders for cancer treatment

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
January 22, 2019
0
Date of Patent
October 15, 2024
0
Patent Application Number
16962816
0
Patent Citations
‌
US Patent 8232273 Heterocyclic compounds and methods of use
0
‌
US Patent 8580794 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 8691184 Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
0
‌
US Patent 8940737 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
0
‌
US Patent 9096625 BCL-2/BCL-XL inhibitors and therapeutic methods using the same
0
‌
US Patent 9345702 Methods of treatment using selective Bcl-2 inhibitors
0
‌
US Patent 9403856 Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
0
‌
US Patent 10730862 Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase
0
‌
US Patent 10071087 Compositions and methods for selectively depleting senescent cells
0
‌
US Patent 10807977 Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereof
0
•••
Patent Inventor Names
Daohong Zhou
0
Peiyi Zhang
0
Guangrong Zheng
0
Sajid Khan
0
Xuan Zhang
0
Yonghan He
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12118414
0
Patent Primary Examiner
‌
Raymond J. Henley, III
0
CPC Code
‌
A61P 35/00
0
‌
A61K 31/496
0

Find more entities like US Patent 12118414 BCL-2 proteins degraders for cancer treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo